IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Jon Batiste talks new album, 'American Symphony' doc and more

    08:13
  • What is behind Elon Musk’s recent divisive nature?

    04:40
  • Charleston, South Carolina monument honors enslaved ancestors

    03:04
  • Mary Cleave, pioneering NASA astronaut, dies at 76

    02:11
  • Family welcomes newborn to the world with Sunday Mug Shot

    01:40
  • Suspect arrested in homeless killings was already in police custody

    00:21
  • Ron DeSantis on Iowa caucus: ‘We’re going to win’

    02:13
  • Trump and DeSantis make dueling campaign appearances in Iowa

    01:50
  • Israel shifts offensive to southern Gaza in hunt of Hamas leaders

    02:03
  • Reba McEntire on her start in music, family and Solo cups

    08:08
  • Former children’s hospital patient joins Iowa Hawkeyes football team

    03:43
  • How artificial intelligence can pick out holiday gifts for you

    03:56
  • Lyn McLain, ‘father of American youth orchestra,’ dies at 95

    01:50
  • Dog sledding in Canada for Sunday Mug Shots!

    01:25
  • Derek Chauvin expected to survive after prison stabbing

    00:24
  • Pope Francis cancels appearance for reported illness

    00:24
  • Sunday after Thanksgiving could be biggest travel day ever

    01:58
  • Stormy weather could delay Thanksgiving weekend travel

    01:29
  • Biden pushes for American hostages to be released by Hamas

    02:31
  • US officials have ‘reason to believe’ an American hostage may be freed today

    01:24

New drugs revolutionizing weight-loss and health care

04:34

The FDA has approved Zepbound, the latest in a growing number of drugs that are revolutionizing weight loss as America faces an epidemic of obesity. Will insurance companies begin to cover the cost and are doctors sure they are safe? NBC’s Liz Kreutz reports in this week’s Sunday Focus. **CORRECTION: An earlier version of this story incorrectly stated that Eli Lilly’s Mounjaro has only been approved for people with pre-diabetes. It has now been updated to reflect that Mounjaro has been approved for people with pre-diabetes and Type 2 diabetes.**